Inventor · disambiguated record
Yi Fan
Also filed as: FAN YI · FAN YI CHIAO
45 granted patents·32 pending applications·448 citations·filing 2004–2025
98Inventor score
Files withVITAE PHARMACEUTICALS LLC19VITAE PHARMACEUTICALS INC15ARBUTUS BIOPHARMA CORP13IRM LLC7ALTEROME THERAPEUTICS INC5
Top patents by PatentIndex Score
77 records- 0196US9102671B2Compounds and compositions as TRK inhibitorsMOLTENI VALENTINA·Filed 2012·Granted Aug 11, 2015·80 cites·19 claims
- 0296US7582667B2Dihydrospiro[dibenzo[a,d][7]annulene-5,4′-imidazol] compounds for the inhibition of beta-secretaseWYETH CORP·Filed 2007·Granted Sep 1, 2009·41 cites·11 claims
- 0395US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0495US9663515B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·13 cites·15 claims
- 0594US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 0694US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 0794US7750021B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2008·Granted Jul 6, 2010·34 cites·8 claims
- 0893US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 0993US9868748B2Thiazolopyrrolidine inhibitors of ROR- γVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·13 cites·19 claims
- 1093US9796710B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·12 cites·14 claims
- 1193US8637516B2Compounds and compositions as TRK inhibitorsFAN YI·Filed 2011·Granted Jan 28, 2014·82 cites·29 claims
- 1292US10087184B2Dihydropyrrolopyridine inhibitors of RORγVITAE PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·10 cites·13 claims
- 1391US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 1491US11999730B1AKT1 modulatorsALTEROME THERAPEUTICS INC·Filed 2023·Granted Jun 4, 2024·2 cites·29 claims
- 1591US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 1690US7939519B2Immunosuppresant compounds and compositionsNOVARTIS AG·Filed 2008·Granted May 10, 2011·14 cites·2 claims
- 1788US10899758B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jan 26, 2021·6 cites·25 claims
- 1888US10301261B2Substituted indoles as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 28, 2019·6 cites·22 claims
- 1987US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 2087US7417065B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2004·Granted Aug 26, 2008·28 cites·10 claims
- 2186US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 2286US9416135B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Aug 16, 2016·4 cites·27 claims
- 2385US11739085B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Aug 29, 2023·1 cites·21 claims
- 2484US9637514B1Oxysterols and hedgehog signalingMAX BIOPHARMA INC·Filed 2016·Granted May 2, 2017·2 cites·20 claims
- 2584US9006244B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2015·5 cites·49 claims
- 2682US10829448B2Substituted benzoimidazoles as modulators of ROR-γVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Nov 10, 2020·1 cites·6 claims
- 2781US12083118B2Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2019·Granted Sep 10, 2024·2 cites·26 claims
- 2880US9845308B2Isoindoline inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 19, 2017·2 cites·12 claims
- 2980US8507488B2Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitorsALBAUGH PAMELA A·Filed 2009·Granted Aug 13, 2013·10 cites·15 claims
- 3079US11001583B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted May 11, 2021·1 cites·11 claims
- 3179US2025092040A1Akt1 modulatorsALTEROME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3278US2025326764A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 3377US12209087B2AKT1 modulatorsALTEROME THERAPEUTICS INC·Filed 2024·Granted Jan 28, 2025·0 cites·20 claims
- 3477US10829481B2Benzimidazole derivatives as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Nov 10, 2020·1 cites·22 claims
- 3577US2025346610A1SUBSTITUTED PYRIDO[4,3-d]PYRIMIDINES AS KRAS MODULATORSALTEROME THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3675US9707232B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·1 cites·19 claims
- 3775US8101608B2Compounds and compositions as protein kinase inhibitorsWAN YONGQIN·Filed 2005·Granted Jan 24, 2012·5 cites·10 claims
- 3875US2024124447A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 3974US7462629B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2004·Granted Dec 9, 2008·7 cites·11 claims
- 4074US2024374595A1Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using sameARBUTUS BIOPHARMA CORP·Filed 2024·Application pending·0 cites
- 4173US12466842B2Substituted pyrido [4,3-d]pyrimidines as KRAS modulatorsALTEROME THERAPEUTICS INC·Filed 2025·Granted Nov 11, 2025·0 cites·30 claims
- 4272US11008340B2Modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 18, 2021·1 cites·14 claims
- 4372US9388190B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 12, 2016·1 cites·16 claims
- 4469US7256206B2Bicyclic compounds and compositionsIRM LLC·Filed 2004·Granted Aug 14, 2007·5 cites·5 claims
- 4568US2024400555A1Compounds, Compositions and Methods for Attenuation of Mammalian Translation of C-MYC or N-MYC Proteins of the MYC Proto-Oncogene Family of BHLH Transcription FactorsINITIAL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4667US2021300869A1Modulators of ror-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 4766US12378193B2Anti-arrhythmicity agentsUNIV CALIFORNIA·Filed 2022·Granted Aug 5, 2025·0 cites·8 claims
- 4865US2020138812A1Liver x receptor modulatorsVITAE PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 4962US2021094940A1Modulators of ror-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 5062US2022340573A11,2,4-oxadiazole derivatives as liver x receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
Showing the top 50 of 77 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yi Fan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →